Changes/additions to materials (reviewed 23rd June 2010):

Since these materials were published NICE has published a new clinical guideline on the pharmacological management of neuropathic pain in adults in non-specialist settings (CG96). This updates and replaces recommendations on the drug treatment of painful diabetic neuropathy in previous NICE clinical guidelines on type 1 (CG15) and type 2 diabetes (CG87). More information is available in a blog.

Part 5 of the e-learning event on this floor of NPCi specifically discusses the evidence-base for the pharmacological treatment of neuropathic pain. A brand new NPCi floor on neuropathic pain is currently under development to take into account this new NICE guidance and will be available later in 2010.

We have produced data-focussed commentaries to highlight areas where there appear to be differences between the evidence-base, as described elsewhere on this floor, and current clinical practice. These resources can be read on the screen by clicking the 'flash' version, or by downloading and printing the 'PDF' version.

This commentary covers the use of tramadol, oxycodone and fentanyl patches.